Can Exercise Benefits Be Harnessed with Drugs? A New Way to Combat Neurodegenerative Diseases by Boosting Neurogenesis

Overview

Journal Transl Neurodegener

Publisher Biomed Central

Date 2024 Jul 25

PMID 39049102

Authors

Renqing Zhao

Affiliations

Soon will be listed here.

Abstract

Adult hippocampal neurogenesis (AHN) is affected by multiple factors, such as enriched environment, exercise, ageing, and neurodegenerative disorders. Neurodegenerative disorders can impair AHN, leading to progressive neuronal loss and cognitive decline. Compelling evidence suggests that individuals engaged in regular exercise exhibit higher production of proteins that are essential for AHN and memory. Interestingly, specific molecules that mediate the effects of exercise have shown effectiveness in promoting AHN and cognition in different transgenic animal models. Despite these advancements, the precise mechanisms by which exercise mimetics induce AHN remain partially understood. Recently, some novel exercise molecules have been tested and the underlying mechanisms have been proposed, involving intercommunications between multiple organs such as muscle-brain crosstalk, liver-brain crosstalk, and gut-brain crosstalk. In this review, we will discuss the current evidence regarding the effects and potential mechanisms of exercise mimetics on AHN and cognition in various neurological disorders. Opportunities, challenges, and future directions in this research field are also discussed.

References

Zhang F, Hou G, Hou G, Wang C, Shi B, Zheng Y . Serum Irisin as a Potential Biomarker for Cognitive Decline in Vascular Dementia. Front Neurol. 2021; 12:755046. PMC: 8473826. DOI: 10.3389/fneur.2021.755046. View

Seki T, Hori T, Miyata H, Maehara M, Namba T . Analysis of proliferating neuronal progenitors and immature neurons in the human hippocampus surgically removed from control and epileptic patients. Sci Rep. 2019; 9(1):18194. PMC: 6890740. DOI: 10.1038/s41598-019-54684-z. View

Terreros-Roncal J, Moreno-Jimenez E, Flor-Garcia M, Rodriguez-Moreno C, Trinchero M, Cafini F . Impact of neurodegenerative diseases on human adult hippocampal neurogenesis. Science. 2021; 374(6571):1106-1113. PMC: 7613437. DOI: 10.1126/science.abl5163. View

Vogt N, Kerby R, Dill-McFarland K, Harding S, Merluzzi A, Johnson S . Gut microbiome alterations in Alzheimer's disease. Sci Rep. 2017; 7(1):13537. PMC: 5648830. DOI: 10.1038/s41598-017-13601-y. View

Marxreiter F, Regensburger M, Winkler J . Adult neurogenesis in Parkinson's disease. Cell Mol Life Sci. 2012; 70(3):459-73. PMC: 11113680. DOI: 10.1007/s00018-012-1062-x. View

Zhao J, Zhou Y, Guo M, Yue D, Chen C, Liang G . MicroRNA-7: expression and function in brain physiological and pathological processes. Cell Biosci. 2020; 10:77. PMC: 7288475. DOI: 10.1186/s13578-020-00436-w. View

Ayhan F, Kulkarni A, Berto S, Sivaprakasam K, Douglas C, Lega B . Resolving cellular and molecular diversity along the hippocampal anterior-to-posterior axis in humans. Neuron. 2021; 109(13):2091-2105.e6. PMC: 8273123. DOI: 10.1016/j.neuron.2021.05.003. View

McKee S, Reyes T . Effect of supplementation with methyl-donor nutrients on neurodevelopment and cognition: considerations for future research. Nutr Rev. 2018; 76(7):497-511. PMC: 6887696. DOI: 10.1093/nutrit/nuy007. View

Murray D, Sacheli M, Eng J, Stoessl A . The effects of exercise on cognition in Parkinson's disease: a systematic review. Transl Neurodegener. 2014; 3(1):5. PMC: 3936925. DOI: 10.1186/2047-9158-3-5. View

10.

Wang Q, Luo Y, Chaudhuri K, Reynolds R, Tan E, Pettersson S . The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options. Brain. 2021; 144(9):2571-2593. DOI: 10.1093/brain/awab156. View

11.

Sharma S, Taliyan R, Singh S . Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: Modulation of histone deacetylase activity. Behav Brain Res. 2015; 291:306-314. DOI: 10.1016/j.bbr.2015.05.052. View

12.

Altuna M, Urdanoz-Casado A, de Gordoa J, Zelaya M, Labarga A, Lepesant J . DNA methylation signature of human hippocampus in Alzheimer's disease is linked to neurogenesis. Clin Epigenetics. 2019; 11(1):91. PMC: 6585076. DOI: 10.1186/s13148-019-0672-7. View

13.

Ieraci A, Madaio A, Mallei A, Lee F, Popoli M . Brain-Derived Neurotrophic Factor Val66Met Human Polymorphism Impairs the Beneficial Exercise-Induced Neurobiological Changes in Mice. Neuropsychopharmacology. 2016; 41(13):3070-3079. PMC: 5101555. DOI: 10.1038/npp.2016.120. View

14.

Islam M, Valaris S, Young M, Haley E, Luo R, Bond S . Exercise hormone irisin is a critical regulator of cognitive function. Nat Metab. 2021; 3(8):1058-1070. PMC: 10317538. DOI: 10.1038/s42255-021-00438-z. View

15.

Esteves M, Serra-Almeida C, Saraiva C, Bernardino L . New insights into the regulatory roles of microRNAs in adult neurogenesis. Curr Opin Pharmacol. 2019; 50:38-45. DOI: 10.1016/j.coph.2019.11.003. View

16.

Noda Y, Kuzuya A, Tanigawa K, Araki M, Kawai R, Ma B . Fibronectin type III domain-containing protein 5 interacts with APP and decreases amyloid β production in Alzheimer's disease. Mol Brain. 2018; 11(1):61. PMC: 6201590. DOI: 10.1186/s13041-018-0401-8. View

17.

Pellegrini C, Pirazzini C, Sala C, Sambati L, Yusipov I, Kalyakulina A . A Meta-Analysis of Brain DNA Methylation Across Sex, Age, and Alzheimer's Disease Points for Accelerated Epigenetic Aging in Neurodegeneration. Front Aging Neurosci. 2021; 13:639428. PMC: 8006465. DOI: 10.3389/fnagi.2021.639428. View

18.

Gao L, Tian M, Zhao H, Xu Q, Huang Y, Si Q . TrkB activation by 7, 8-dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease. J Neurochem. 2015; 136(3):620-36. DOI: 10.1111/jnc.13432. View

19.

Khezri M, Yousefi K, Mahboubi N, Hodaei D, Ghasemnejad-Berenji M . Metformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findings. Biochem Pharmacol. 2022; 197:114945. DOI: 10.1016/j.bcp.2022.114945. View

20.

Hoglinger G, Rizk P, Muriel M, Duyckaerts C, Oertel W, Caille I . Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci. 2004; 7(7):726-35. DOI: 10.1038/nn1265. View